Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
Zezheng Liu,1,* Wenquan Liang,1,* Dawei Kang,1 Qingjing Chen,1 Zhicong Ouyang,1 Huibo Yan,1 Bin Huang,1 Dadi Jin,1 Yinkui Chen,2 Qingchu Li1 1Academy of Orthopedics, Guangdong Province, Department of Spine Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People&r...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c618969718b040b180b0e33c4d75bddc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c618969718b040b180b0e33c4d75bddc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c618969718b040b180b0e33c4d75bddc2021-12-02T12:13:09ZIncreased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis1178-1998https://doaj.org/article/c618969718b040b180b0e33c4d75bddc2020-07-01T00:00:00Zhttps://www.dovepress.com/increased-osteoblastic-cxcl9-contributes-to-the-uncoupled-bone-formati-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Zezheng Liu,1,* Wenquan Liang,1,* Dawei Kang,1 Qingjing Chen,1 Zhicong Ouyang,1 Huibo Yan,1 Bin Huang,1 Dadi Jin,1 Yinkui Chen,2 Qingchu Li1 1Academy of Orthopedics, Guangdong Province, Department of Spine Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qingchu LiDepartment of Spine Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of ChinaEmail lqc16@263.netYinkui ChenDepartment of Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of ChinaEmail clytze2@126.comIntroduction: Estrogen deficiency leads to bone loss in postmenopausal osteoporosis, because bone formation, albeit enhanced, fails to keep pace with the stimulated osteoclastic bone resorption. The mechanism driving this uncoupling is central to the pathogenesis of postmenopausal osteoporosis, which, however, remains poorly understood. We previously found that Cxcl9 secreted by osteoblasts inhibited osteogenesis in bone, while the roles of Cxcl9 on osteoclastic bone resorption and osteoporosis are unclear.Materials and Methods: Postmenopausal osteoporosis mouse model was established by bilateral surgical ovariectomy (OVX). In situ hybridization was performed to detect Cxcl9 mRNA expression in bone. ELISA assay was conducted to assess Cxcl9 concentrations in bone and serum. Cxcl9 activity was blocked by its neutralizing antibody. Micro-CT was performed to determine the effects of Cxcl9 neutralization on bone structure. Cell Migration and adhesion assay were conducted to evaluate the effects of Cxcl9 on osteoclast activity. TRAP staining and Western blot were performed to assess osteoclast differentiation. CXCR3 antagonist NBI-74,330 or ERK antagonist SCH772984 was administered to osteoclast to study the effects of Cxcl9 on CXCR3/ERK signaling.Results: Cxcl9 was expressed and secreted increasingly in OVX mice bone. Neutralizing Cxcl9 in bone marrow prevented bone loss in the mice by facilitating bone formation as well as inhibiting bone resorption. In vitro, Cxcl9 secreted from osteoblasts facilitated osteoclast precursors adhesion, migration and their differentiation into mature osteoclasts. The positive role of osteoblastic Cxcl9 on osteoclasts was eliminated by blocking CXCR3/ERK signaling in osteoclasts. Estrogen negatively regulated Cxcl9 expression and secretion in osteoblasts, explaining the increased Cxcl9 concentration in OVX mice bone.Conclusion: Our study illustrates the roles of Cxcl9 in inhibiting bone formation and stimulating bone resorption in osteoporotic bone, therefore providing a possible therapeutic target to the treatment of postmenopausal osteoporosis.Keywords: postmenopausal osteoporosis, bone resorption, osteoclast, Cxcl9Liu ZLiang WKang DChen QOuyang ZYan HHuang BJin DChen YLi QDove Medical Pressarticlepostmenopausal osteoporosisbone resorptionosteoclastcxcl9GeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 1201-1212 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
postmenopausal osteoporosis bone resorption osteoclast cxcl9 Geriatrics RC952-954.6 |
spellingShingle |
postmenopausal osteoporosis bone resorption osteoclast cxcl9 Geriatrics RC952-954.6 Liu Z Liang W Kang D Chen Q Ouyang Z Yan H Huang B Jin D Chen Y Li Q Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
description |
Zezheng Liu,1,* Wenquan Liang,1,* Dawei Kang,1 Qingjing Chen,1 Zhicong Ouyang,1 Huibo Yan,1 Bin Huang,1 Dadi Jin,1 Yinkui Chen,2 Qingchu Li1 1Academy of Orthopedics, Guangdong Province, Department of Spine Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qingchu LiDepartment of Spine Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of ChinaEmail lqc16@263.netYinkui ChenDepartment of Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People’s Republic of ChinaEmail clytze2@126.comIntroduction: Estrogen deficiency leads to bone loss in postmenopausal osteoporosis, because bone formation, albeit enhanced, fails to keep pace with the stimulated osteoclastic bone resorption. The mechanism driving this uncoupling is central to the pathogenesis of postmenopausal osteoporosis, which, however, remains poorly understood. We previously found that Cxcl9 secreted by osteoblasts inhibited osteogenesis in bone, while the roles of Cxcl9 on osteoclastic bone resorption and osteoporosis are unclear.Materials and Methods: Postmenopausal osteoporosis mouse model was established by bilateral surgical ovariectomy (OVX). In situ hybridization was performed to detect Cxcl9 mRNA expression in bone. ELISA assay was conducted to assess Cxcl9 concentrations in bone and serum. Cxcl9 activity was blocked by its neutralizing antibody. Micro-CT was performed to determine the effects of Cxcl9 neutralization on bone structure. Cell Migration and adhesion assay were conducted to evaluate the effects of Cxcl9 on osteoclast activity. TRAP staining and Western blot were performed to assess osteoclast differentiation. CXCR3 antagonist NBI-74,330 or ERK antagonist SCH772984 was administered to osteoclast to study the effects of Cxcl9 on CXCR3/ERK signaling.Results: Cxcl9 was expressed and secreted increasingly in OVX mice bone. Neutralizing Cxcl9 in bone marrow prevented bone loss in the mice by facilitating bone formation as well as inhibiting bone resorption. In vitro, Cxcl9 secreted from osteoblasts facilitated osteoclast precursors adhesion, migration and their differentiation into mature osteoclasts. The positive role of osteoblastic Cxcl9 on osteoclasts was eliminated by blocking CXCR3/ERK signaling in osteoclasts. Estrogen negatively regulated Cxcl9 expression and secretion in osteoblasts, explaining the increased Cxcl9 concentration in OVX mice bone.Conclusion: Our study illustrates the roles of Cxcl9 in inhibiting bone formation and stimulating bone resorption in osteoporotic bone, therefore providing a possible therapeutic target to the treatment of postmenopausal osteoporosis.Keywords: postmenopausal osteoporosis, bone resorption, osteoclast, Cxcl9 |
format |
article |
author |
Liu Z Liang W Kang D Chen Q Ouyang Z Yan H Huang B Jin D Chen Y Li Q |
author_facet |
Liu Z Liang W Kang D Chen Q Ouyang Z Yan H Huang B Jin D Chen Y Li Q |
author_sort |
Liu Z |
title |
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
title_short |
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
title_full |
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
title_fullStr |
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
title_full_unstemmed |
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis |
title_sort |
increased osteoblastic cxcl9 contributes to the uncoupled bone formation and resorption in postmenopausal osteoporosis |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/c618969718b040b180b0e33c4d75bddc |
work_keys_str_mv |
AT liuz increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT liangw increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT kangd increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT chenq increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT ouyangz increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT yanh increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT huangb increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT jind increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT cheny increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis AT liq increasedosteoblasticcxcl9contributestotheuncoupledboneformationandresorptioninpostmenopausalosteoporosis |
_version_ |
1718394599105363968 |